The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the country’s leading biopharmaceutical researchers and biotechnology companies.

are led by the biopharmaceutical industry

were volunteering, in 2013, in clinical studies across the country

of clinical trials are currently ongoing or underway

are supported by America's biopharmaceutical companies

of all Medicare acute hospitals participate in 340B.

340B sites enrolled as of May 2015.

88%

decline in HIV/AIDS death rates

since the 1990s

of 340B volume goes through DSH hospitals even though they make up just 9% of 340B entities.

have been delivered to patients, thanks to PDUFA.

are in clinical testing for cancer

Approved by the Food and Drug Administration since 2000.

$2.6

Billion

The average cost to develop one new medicine.

8

months

Priority FDA review time thanks to PDUFA

in the pipeline, as of 2015, have the potential to be personalized medicines.

to treat diabetes

have been identified to-date

Average yearly amount PhRMA Foundation awards to young scientists.

7,000

New Medicines

Currently in development around the world.